Skip to main content

Health & Wellbeing

Biomed Europa

Biomed Europa: A challenge to the pharmaceutical oligopoly

In his new white paper, “Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly,” Italian economist Massimo Florio proposes an international, transparent, public phar read more
Pharmacist holding medicines

Four steps toward reclaiming public medicine for public health

Now is the time to redesign our medicines system around open science practices, full-cycle public pharmaceutical production, compulsory licensing, and public ownership of the vaccine industry. read more
VA for all

Create a “VA for all” 

In our lifetime, it has perhaps never been clearer that we need a single, coordinated public healthcare system with equal access for all—a read more

System Change magazine highlights a year of bold ideas

The Democracy Collaborative and the Next System Project has published System Change, a magazine that captures the bold ideas and groundbreaking work of our leaders and scholars in 2019. read more
A blister pack of medicine in pill form

Commitments to public pharmaceutical production in the Democratic primary

Our report Medicine For All: The Case for a Public Option in the Pharmaceutical Industry  argues that truly making pharmaceuticals accessible and affordable for all Americans will require public ownership of pharmaceutical production read more
A pipette being dipped into an array of testtubes

A National Pharmaceutical Research and Development Institute

To promote the execution of pharmaceutical R&D in the public interest, the US should establish a national pharmaceutical R&D institute for full-cycle drug development, which will help promote long-term access to medicines, reignite innovation, and ensure prioritization of public health needs. read more
Lower drug prices now

Lower drug costs now through a pharmaceutical public option

House Speaker Nancy Pelosi on September 19 released the “Lower Drug Costs Now Act” (H.R. 3), which would institute a series of measure read more
Prescription drug costs image by TaxRebate.org.uk via Flickr

The Case for a Public Option for the Drug Industry

Under siege from thousands of lawsuits from federal, state, and local governments for its role in the deadly opioid addiction crisis, drug manufacturer Purdue Pharma reached read more
Default Image: Glass Facade

Combatting the care crisis

As the home care industry faces a labor shortage, hospitals and health systems could use their status as anchor institutions to bolster the sector and improve community well-being.  read more